Abbvie, Lda secures contract for Risancizumab 600 Mg 10 Ml Sol Inj Fr 10 Ml Iv Aue 202503591

Portugal, March 26 -- Portugal based Abbvie, Lda has secured contract from Unidade Local De Saude De Almada-Seixal, Epe for Risancizumab 600 Mg 10 Ml Sol Inj Fr 10 Ml Iv Aue 202503591. The value of the contract is worth 553149 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....